Risk factor
Very high price volatility
Profitability factor
Very strong margins and returns
About
Shukra Pharmaceuticals Ltd. manufactures and markets pharmaceutical products in both domestic and international markets. Its portfolio includes antibiotics, macrolides, quinolones, anti bacterial, anti fungal, anti malarial, anti viral, anti protozoal, anti anthelmintic, sedative and tranquilliser, anti depressant, anti manic, anti emetic, anti ulcer, beta blockers, diuretics, analgesic, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic. The company was founded on March 4, 1993 and is headquartered in Ahmedabad, India.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI
Buy
Sell